In 2023, hospital discharges for urolithiasis cases in Canada were recorded at 13.7 thousand. The forecast from 2024 to 2028 shows a consistent decline in discharges: 13.31 thousand in 2024, decreasing to 12.05 thousand by 2028. Year-on-year, this represents declines of approximately 2.4% on average, while the five-year compound annual growth rate (CAGR) projects a steady decrease of around 3% per annum.
Future trends to watch for include potential technological advancements in diagnosis and treatment, which may alter discharge rates. Changes in lifestyle factors and healthcare policies could also impact future forecasts for urolithiasis discharges in Canada.
